Published in Multidiscip Respir Med on November 12, 2012
Palliative care and location of death in decedents with idiopathic pulmonary fibrosis. Chest (2015) 1.85
Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study. BMC Pulm Med (2016) 0.82
Depression in pulmonary arterial hypertension and interstitial lung diseases. N Am J Med Sci (2014) 0.81
Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis. BMC Pulm Med (2016) 0.77
A Systematic Review of the Role of Dysfunctional Wound Healing in the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis. J Clin Med (2016) 0.75
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med (2005) 7.20
Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 6.71
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med (2012) 6.51
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet (2011) 5.94
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med (2012) 5.33
International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant (2006) 4.95
Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1998) 4.88
A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2012) 4.81
Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet (1998) 4.69
Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med (2001) 4.45
Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med (2005) 4.25
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med (2010) 4.19
Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med (2011) 3.85
Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med (2003) 3.81
BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 3.49
Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 3.37
Gene expression profiling of familial and sporadic interstitial pneumonia. Am J Respir Crit Care Med (2006) 3.32
BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 3.23
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet (2009) 3.21
Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest (2005) 3.02
High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J (2006) 2.94
Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease. Ann Thorac Surg (2007) 2.73
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest (2006) 2.73
The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (2000) 2.63
Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. Am J Respir Crit Care Med (2011) 2.62
Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest (2010) 2.51
Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest (2011) 2.49
Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J (1961) 2.46
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J (2009) 2.41
Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 2.32
Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics (2010) 2.32
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 2.20
Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J (2002) 2.19
Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med (2007) 2.13
Sarcoidosis: challenging diagnostic aspects of an old disease. Am J Med (2012) 2.10
Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax (2002) 2.07
The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. Am J Respir Crit Care Med (2008) 2.02
Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest (2004) 1.95
Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med (2007) 1.94
Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 1.88
Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. Chest (2001) 1.87
Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. Am J Respir Crit Care Med (2002) 1.78
Framework for evaluating disease severity measures in older adults with comorbidity. J Gerontol A Biol Sci Med Sci (2007) 1.75
Idiopathic pulmonary fibrosis in asbestos-exposed workers. Am Rev Respir Dis (1991) 1.67
Interstitial lung disease in connective tissue disorders. Lancet (2012) 1.67
Sildenafil improves walk distance in idiopathic pulmonary fibrosis. Chest (2007) 1.66
Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg (2003) 1.60
Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med (2005) 1.56
Lung transplant in idiopathic pulmonary fibrosis. Arch Surg (2011) 1.53
Familial idiopathic pulmonary fibrosis: clinical features and outcome. Chest (2005) 1.34
Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology (2008) 1.32
Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med (2010) 1.30
High lung allocation score is associated with increased morbidity and mortality following transplantation. Chest (2009) 1.22
Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax (2008) 1.18
Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur Respir J (2007) 1.13
Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society. Arch Pathol Lab Med (2010) 1.11
Chronic hypersensitivity pneumonitis. Clin Chest Med (2012) 1.10
Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. Am J Respir Crit Care Med (2011) 1.09
Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. Chest (2001) 1.08
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis (2011) 1.07
Patient experiences with pulmonary fibrosis. Respir Med (2006) 1.07
The roentgenographic staging of sarcoidosis. Historic and contemporary perspectives. Chest (1983) 1.07
Biopsy-proved idiopathic pulmonary fibrosis: spectrum of nondiagnostic thin-section CT diagnoses. Radiology (2010) 1.06
Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. Respir Med (2010) 1.03
Comprehensive care of the patient with idiopathic pulmonary fibrosis. Curr Opin Pulm Med (2011) 1.02
Acute exacerbation of idiopathic pulmonary fibrosis: a systematic review. Eur J Intern Med (2008) 0.99
Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis. J Rheumatol (2006) 0.97
An earlier and more confident diagnosis of idiopathic pulmonary fibrosis. Eur Respir Rev (2012) 0.96
Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Eur Respir J (2011) 0.95
The big clinical trials in idiopathic pulmonary fibrosis. Curr Opin Pulm Med (2012) 0.90
Depression and functional status are strongly associated with dyspnea in interstitial lung disease. Chest (2010) 0.87
Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis. Palliat Med (2005) 0.85
Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease. Eur Respir Rev (2009) 0.84
Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT. Clin Radiol (1996) 0.83
Chest pain in the presentation of sarcoidosis. Br J Dis Chest (1976) 0.80
Outcomes of patients admitted to the intensive care unit with idiopathic pulmonary fibrosis. Crit Care Resusc (2009) 0.80
Management of idiopathic pulmonary fibrosis. Clin Chest Med (2011) 0.80
Pulmonary sarcoidosis with usual interstitial pneumonia distributed predominantly in the lower lung fields. Intern Med (2006) 0.79
Pleural plaques: a review of diagnostic issues and possible nonasbestos factors. Arch Environ Occup Health (2007) 0.79
Clinical, radiological, and pathological investigation of asbestosis. Int J Environ Res Public Health (2011) 0.78
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med (2013) 6.82
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med (2015) 6.03
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet (2006) 5.19
Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med (2005) 4.06
Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport (2005) 3.80
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol (2010) 2.64
Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J (2012) 2.57
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma. Proc Natl Acad Sci U S A (2005) 2.19
Sarcoidosis: challenging diagnostic aspects of an old disease. Am J Med (2012) 2.10
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain (2010) 2.01
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement (2011) 1.87
Non-steroid agents for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev (2010) 1.66
Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good. Thorax (2012) 1.65
Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study. Am J Respir Crit Care Med (2009) 1.54
Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor. Cytotherapy (2011) 1.54
Role of blebs and bullae detected by high-resolution computed tomography and recurrent spontaneous pneumothorax. Ann Thorac Surg (2012) 1.54
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med (2013) 1.51
Effects of deep brain stimulation of the peduncolopontine area on working memory tasks in patients with Parkinson's disease. Parkinsonism Relat Disord (2009) 1.45
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb) (2011) 1.34
Idiopathic pulmonary fibrosis: lung function is a clinically meaningful endpoint for phase III trials. Am J Respir Crit Care Med (2012) 1.26
European consensus on a competency-based virtual reality training program for basic endoscopic surgical psychomotor skills. Surg Endosc (2010) 1.17
Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics (2009) 1.14
Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid. Proteomics (2006) 1.11
Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials. Respir Res (2013) 1.10
Neglected evidence in idiopathic pulmonary fibrosis and the importance of early diagnosis and treatment. Eur Respir Rev (2014) 1.10
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease. J Neuroinflammation (2012) 1.08
Interferon gamma assays for tuberculosis. Lancet Infect Dis (2005) 1.08
Re: Stereotactic microdialysis of the basal ganglia in Parkinson's disease. J Neurosci Methods (2013) 1.06
p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells. Oncol Rep (2005) 1.05
Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. Eur J Cardiothorac Surg (2005) 1.04
The MYCN oncogene as a specific and selective drug target for peripheral and central nervous system tumors. Curr Cancer Drug Targets (2005) 1.03
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease. Eur J Neurosci (2006) 0.99
Bronchopulmonary actinomycosis associated with hiatal hernia. Mayo Clin Proc (2009) 0.98
MLL-AF9 oncogene expression affects cell growth but not terminal differentiation and is downregulated during monocyte-macrophage maturation in AML-M5 THP-1 cells. Oncogene (2003) 0.98
Lamotrigine derivatives and riluzole inhibit INa,P in cortical neurons. Neuroreport (2002) 0.98
Idiopathic pulmonary fibrosis: current and future treatment options. Am J Respir Med (2002) 0.96
In vivo bioluminescence imaging of murine xenograft cancer models with a red-shifted thermostable luciferase. Mol Imaging Biol (2009) 0.95
Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease. J Neurosurg (2004) 0.95
Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis. Respir Med (2012) 0.94
Emerging drugs for idiopathic pulmonary fibrosis. Expert Opin Emerg Drugs (2011) 0.94
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients. AIDS (2003) 0.90
The big clinical trials in idiopathic pulmonary fibrosis. Curr Opin Pulm Med (2012) 0.90
Surgical treatment of bronchiectasis: early and long-term results. Interact Cardiovasc Thorac Surg (2008) 0.89
Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one-year follow-up. Sleep (2012) 0.89
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. Autoimmun Rev (2012) 0.89
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. Synapse (2008) 0.88
Application of 2-D DIGE to formalin-fixed, paraffin-embedded tissues. Proteomics (2011) 0.87
Pedunculopontine nucleus deep brain stimulation changes spinal cord excitability in Parkinson's disease patients. J Neural Transm (Vienna) (2008) 0.87
Room size is the major determinant for tuberculin conversion in health care workers exposed to a multidrug-resistant tuberculosis patient. Int Arch Occup Environ Health (2006) 0.87
The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg (2004) 0.87
Bilateral Implantation of Centromedian-Parafascicularis Complex and GPi: A New Combination of Unconventional Targets for Deep Brain Stimulation in Severe Parkinson Disease. Neuromodulation (2006) 0.87
Transient suppression of MLH1 allows effective single-nucleotide substitution by single-stranded DNA oligonucleotides. Mutat Res (2011) 0.87
Idiopathic pulmonary fibrosis: CT and risk of death. Radiology (2014) 0.87
Clinical and genetic study of a large SPG4 Italian family. Mov Disord (2005) 0.86
Proteomic analysis of formalin-fixed, paraffin-embedded lung neuroendocrine tumor samples from hospital archives. J Proteomics (2010) 0.86
Down-regulation of MLL-AF9, MLL and MYC expression is not obligatory for monocyte-macrophage maturation in AML-M5 cell lines carrying t(9;11)(p22;q23). Oncol Rep (2006) 0.86
The Italian register for diffuse infiltrative lung disorders (RIPID): a four-year report. Sarcoidosis Vasc Diffuse Lung Dis (2005) 0.86
Targeted inhibition of NMYC by peptide nucleic acid in N-myc amplified human neuroblastoma cells: cell-cycle inhibition with induction of neuronal cell differentiation and apoptosis. Int J Oncol (2004) 0.86
Recommendations on treatment for IPF. Respir Res (2013) 0.86
The role of biomarkers in low respiratory tract infections. Eur J Intern Med (2012) 0.85
The pharmacological blockade of medial forebrain bundle induces an acute pathological synchronization of the cortico-subthalamic nucleus-globus pallidus pathway. J Physiol (2009) 0.85
Idiopathic pulmonary fibrosis: current challenges and future perspectives. Eur Respir Rev (2013) 0.85
Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease. Parkinsonism Relat Disord (2008) 0.85
Alexithymia is a non-motor symptom of Parkinson disease. Am J Geriatr Psychiatry (2012) 0.84
Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis. Chest (2014) 0.84
High-frequency stimulation of the subthalamic nucleus modulates the activity of pedunculopontine neurons through direct activation of excitatory fibres as well as through indirect activation of inhibitory pallidal fibres in the rat. Eur J Neurosci (2007) 0.84
Multicenter study report: electrophysiological monitoring procedures for subthalamic deep brain stimulation surgery in Parkinson's disease. Neurol Sci (2010) 0.84
Peripeduncular and pedunculopontine nuclei: a dispute on a clinically relevant target. Neuroreport (2007) 0.83
Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patients. PLoS One (2013) 0.83
Pirfenidone. Nat Rev Drug Discov (2011) 0.83
Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practice. J Infect (2006) 0.83
Environmental triggers and susceptibility factors in idiopathic granulomatous diseases. Semin Respir Crit Care Med (2009) 0.83
Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection. Arch Immunol Ther Exp (Warsz) (2009) 0.82
Treatments for idiopathic pulmonary fibrosis. N Engl J Med (2014) 0.82
Prognostic factors and survival after resection of lung metastases from epithelial tumours. Interact Cardiovasc Thorac Surg (2006) 0.82
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report. Mult Scler (2012) 0.81
Atypical lipomatous tumour (lipoma-like well-differentiated liposarcoma) arising in a pulmonary hamartoma and clinically presenting with pneumothorax. Lung Cancer (2003) 0.81
Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease. Ann Nucl Med (2013) 0.81
End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 0.81
FDG small animal PET permits early detection of malignant cells in a xenograft murine model. Eur J Nucl Med Mol Imaging (2006) 0.81
Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease. Parkinsonism Relat Disord (2012) 0.81
Intensity-dependent facial emotion recognition and cognitive functions in Parkinson's disease. J Int Neuropsychol Soc (2010) 0.80
STN versus PPN-DBS for alleviating freezing of gait: toward a frequency modulation approach? Mov Disord (2009) 0.80
L-dopa modulates motor cortex excitability in Alzheimer's disease patients. J Neural Transm (Vienna) (2008) 0.80
Angiogenesis and nerve regeneration in a model of human skin equivalent transplant. Life Sci (2003) 0.80
Management of idiopathic pulmonary fibrosis. Clin Chest Med (2011) 0.80
Deep brain stimulation of the subthalamic nucleus: All that glitters isn't gold? Mov Disord (2015) 0.80
Ex vivo generation and expansion of anti-tumor cytotoxic T-cell lines derived from patients or their HLA-identical sibling. Int J Cancer (2004) 0.79
Steroid and/or other immunosuppressive therapies in idiopathic interstitial pneumonias: have they still a role? Sarcoidosis Vasc Diffuse Lung Dis (2005) 0.79
Do CSF levels of t-Tau, p-Tau and β₁₋₄₂ amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A ¹²³I-FP-CIT study in the early stages of the disease. Eur J Nucl Med Mol Imaging (2014) 0.79
MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia. Oncotarget (2014) 0.79
Real-time RT-PCR of tyrosine hydroxylase to detect bone marrow involvement in advanced neuroblastoma. Oncol Rep (2003) 0.78
N1 non-small-cell lung cancer. A 20-year surgical experience. Asian Cardiovasc Thorac Ann (2011) 0.78
Acute nigro-striatal blockade alters cortico-striatal encoding: an in vivo electrophysiological study. Exp Neurol (2013) 0.78
Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis. Multidiscip Respir Med (2011) 0.78
Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study. Synapse (2006) 0.78
Whole-cell patch-clamp recording of voltage-sensitive Ca²⁺ channel currents in single cells: heterologous expression systems and neurones. Methods Mol Biol (2013) 0.78
Molecular imaging of neuroblastoma progression in TH-MYCN transgenic mice. Mol Imaging Biol (2013) 0.78